@ETPharma ETPharma
ETPharma posts on X about india, dr reddys, ceo, novo the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [-----] +249%
- [--] Month [-----] +84%
- [--] Months [-------] +108%
- [--] Year [-------] -93%
Mentions: [--] #
- [--] Month [--] -97%
- [--] Months [---] +235%
- [--] Year [---] +251%
Followers: [---] #
- [--] Week [---] +4%
- [--] Month [---] +7.10%
- [--] Months [---] +36%
- [--] Year [---] +116%
CreatorRank: [---------] #
Social Influence
Social category influence stocks 36% countries 29% finance 10%
Social topic influence india 28%, dr reddys #8, ceo 7%, novo 6%, the year 5%, sanofi #93, ai 4%, eli lilly 4%, health 3%, business 3%
Top accounts mentioned or mentioned by @novonordisk @drreddys @sanofi @elilillyandco @economictimes @rokautomation @astrazeneca @sunpharmalive @lupinglobal @ciplaglobal @pfizer @usfda @fda @doptgoi @novartis @bmsnews @zydusuniverse @cdscoindiainf @takedaoncology @astellasus
Top assets mentioned Sanofi (SNY) Eli Lilly and Company (LLY) Novartis AG (NVS) Frontline Ltd. (FRO) AbbVie Inc (ABBV) Terns Pharmaceuticals, Inc. (TERN)
Top Social Posts
Top posts by engagements in the last [--] hours
"Can domestic formulations shield Indian pharma from US pricing pressure in Q3 #Pharma I #India I #Q3_earnings I #FY_26 I @SunPharma_Live I @LupinGlobal I #AUROBINDO I @drreddys I @Cipla_Global I #DIVIS_LABORATORIES Read more: https://pharma.economictimes.indiatimes.com/news/financial-performance/can-domestic-formulations-shield-indian-pharma-from-us-pricing-pressure-in-q3/126555590 https://pharma.economictimes.indiatimes.com/news/financial-performance/can-domestic-formulations-shield-indian-pharma-from-us-pricing-pressure-in-q3/126555590"
X Link 2026-01-16T06:45Z [---] followers, [---] engagements
"* Dr. Shridhar Narayanan Senior Technical Advisor Indian Pharmaceutical Alliance (IPA) * Sagar Sen Senior Vice President Qure ai * Siddharth Iyer Sector Lead Healthcare & Pharma Equirus Capital Moderated by: * Prathiba Raju Senior Assistant Editor ETPharma"
X Link 2026-02-13T08:11Z [---] followers, [--] engagements
"Where innovation meets recognition the #ETRePharmaAwards [----]. A proud celebration of the changemakers who are advancing research strengthening manufacturing and setting new benchmarks in pharmaceutical leadership. Know more: #REPharmaAwards https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T14:52Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] a deep-dive conversation explores: Rethinking Pharma Capabilities: Are GCCs Really the New Nerve Centre Know more: #ETREPharma #REPharmaSummit #PharmaGCC #GlobalCapabilityCenters #DigitalR&D https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T12:09Z [---] followers, [--] engagements
"Sharing frontline insights: Neetta Mohit Global Head of Program Management Innovation & Development Center Abbott India Ankit Srivastava R&D SW India Hub Lead Bayer Moderated by: Prathiba Raju Senior Assistant Editor ETPharma"
X Link 2026-02-13T12:09Z [---] followers, [--] engagements
"Honouring this years distinguished winners: Innovative Drug of the Year Afrezza by Cipla Ltd. Pharmacy Chain of the Year AMRIT Pharmacy by HLL Lifecare Limited Health Awareness Campaign of the Year Choose Your Weight by Novo Nordisk India"
X Link 2026-02-13T14:52Z [---] followers, [--] engagements
"Honouring brilliance that drives Indian pharma forward at the ##ETRePharmaAwards [----]. An evening dedicated to celebrating pathbreaking research bold leadership and transformative impact across the pharmaceutical ecosystem. Know more: #REPharmaAwards https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T14:35Z [---] followers, [--] engagements
"Congratulations to our winners: Excellence in Pharma Contract Services Manufacturing: Aurigene Pharmaceutical Services Limited Excellence in Pharma Global Business Support: HRV Global Life Sciences Private Limited Excellence in Pharma Global Business Support: G&L Scientific"
X Link 2026-02-13T14:38Z [---] followers, [--] engagements
"Health Awareness Campaign of the Year Together Against RSV by Sanofi Excellence in Marketing Mounjaro Launch by Eli Lilly and Company Excellence in Marketing Cipla Assist Excellence in CSR Novo Nordisk Education Foundation (NNEF)"
X Link 2026-02-13T14:52Z [---] followers, [--] engagements
"Join Manikantan NS Sr. VP & Global Head - Manufacturing Tech Mahindra at India Inc on the Move: Smart and Sustainable Manufacturing presented by @EconomicTimes and powered by @ROKAutomation on February [--] [----] Fairmont Mumbai. #IIOTM2026 https://iiotm2026.com/site/iiotm/2346 https://iiotm2026.com/site/iiotm/2346"
X Link 2026-01-29T10:25Z [---] followers, [--] engagements
"Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drug #Nivolumab I #Opdivo I #Cancer I #PD_1 I #Biosimilar I #Patent I #India I #Supreme_Court I @bmsnews I @ZydusUniverse Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/bristol-myers-moves-sc-to-stop-zydus-from-selling-biosimilar-cancer-drug/127788898 https://pharma.economictimes.indiatimes.com/news/pharma-industry/bristol-myers-moves-sc-to-stop-zydus-from-selling-biosimilar-cancer-drug/127788898"
X Link 2026-01-30T02:39Z [---] followers, [--] engagements
"UK industry body says Sanofi in breach over RSV therapy claims against Pfizer #UK I #Pharma I #Industry_body I #self_regulation I #RSV_therapy I @sanofi I @pfizer Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/uk-industry-body-says-sanofi-in-breach-over-rsv-therapy-claims-against-pfizer/127886653 https://pharma.economictimes.indiatimes.com/news/pharma-industry/uk-industry-body-says-sanofi-in-breach-over-rsv-therapy-claims-against-pfizer/127886653"
X Link 2026-02-04T04:52Z [---] followers, [--] engagements
"Indian pharma industry take first steps to phase out animal testing from drug research #animal_test I #pharma I #drugs I #India I #biologics I #biosimilars I #regulations I #US I #EU I @US_FDA I @CDSCO_INDIA_INF I @drreddys Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/indian-pharma-industry-take-first-steps-to-phase-out-animal-testing-from-drug-research/127980454 https://pharma.economictimes.indiatimes.com/news/pharma-industry/indian-pharma-industry-take-first-steps-to-phase-out-animal-testing-from-drug-research/127980454"
X Link 2026-02-06T09:28Z [---] followers, [--] engagements
"At the ET RE-Pharma Summit [----] this high-impact panel discussion will take on one of the industrys most urgent conversations: Breaking the Mould: Indian Pharmas Reckoning with Innovation Fatigue. Register now: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-06T09:55Z [---] followers, [--] engagements
"Dr. Annam Visala Joint Drugs Controller (India) CDSCO Achin Gupta MD and Global CEO Designate Cipla Meenakshi Nevatia Country President & Managing Director Pfizer Sanjiv Navangul MD & CEO Bharat Serums and Vaccines Limited Nandini Piramal Chairperson Piramal Pharma"
X Link 2026-02-06T09:56Z [---] followers, [---] engagements
"Cipla faces GST probe #GST I #Mumbai I #probe I #input_credit I #search I @Cipla_Global Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/cipla-faces-gst-probe/128017429 https://pharma.economictimes.indiatimes.com/news/pharma-industry/cipla-faces-gst-probe/128017429"
X Link 2026-02-07T16:51Z [---] followers, [--] engagements
"At the ET RE-Pharma Summit [----] Ankit Srivastava R&D SW India Hub Lead at Bayer will share insights on how digital R&D hubs are accelerating discovery enabling cross-border collaboration. Register now: #ETREPharma #REPharmaSummit #GCC https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-09T10:30Z [---] followers, [--] engagements
"Takeda deepens AI drug discovery push with $1.7 billion Iambic deal #Pharma I #medicine I #AI I #integration I #Drug_discovery I #partnership I @TakedaOncology Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/takeda-deepens-ai-drug-discovery-push-with-1-7-billion-iambic-deal/128135427 https://pharma.economictimes.indiatimes.com/news/pharma-industry/takeda-deepens-ai-drug-discovery-push-with-1-7-billion-iambic-deal/128135427"
X Link 2026-02-10T02:28Z [---] followers, [--] engagements
"Bhargav Sri Prakash Research Scientist and CEO at FriendsLearn and part of the Carnegie Mellon University Digital Vaccine Project will bring a cutting-edge perspective to the ET RE-Pharma Summit [----]. Register now: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-10T06:32Z [---] followers, [--] engagements
"Siddharth Iyer Sector Lead Healthcare & Pharma at Equirus will bring an investor and sector-analyst lens to the ET RE-Pharma Summit [----] sharing insights on how pharma valuations R&D bets and business models. Register now: #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-10T08:45Z [---] followers, [--] engagements
"Lupin settles Mirabegron patent dispute with Astellas for $90 Mn #Mirabegron I #OAB I #patent I #infringement I #US I #settlement I #90Mn I @LupinGlobal I @AstellasUS Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/lupin-settles-mirabegron-patent-dispute-with-astellas-for-90-mn/128153793 https://pharma.economictimes.indiatimes.com/news/pharma-industry/lupin-settles-mirabegron-patent-dispute-with-astellas-for-90-mn/128153793"
X Link 2026-02-10T10:29Z [---] followers, [--] engagements
"AstraZeneca sees steady growth ahead on strong cancer drug demand #Pharma I #earnings I #cancer_drugs I #growth I #US I #weightloss_plans I @AstraZeneca Read more: https://pharma.economictimes.indiatimes.com/news/financial-performance/astrazeneca-sees-steady-growth-ahead-on-strong-cancer-drug-demand/128183473 https://pharma.economictimes.indiatimes.com/news/financial-performance/astrazeneca-sees-steady-growth-ahead-on-strong-cancer-drug-demand/128183473"
X Link 2026-02-11T02:33Z [---] followers, [--] engagements
"Warburg-Mubadala team up emerge as frontrunner for Encube #Acquisition I #Pharma I #CDMO I #Topical_drugs I #PF_funds I @warburgpincus I @Mubadala I #majority_stake I #IPO I @encubeethicals Read more: https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/warburg-mubadala-team-up-emerge-as-frontrunner-for-encube/128183510 https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/warburg-mubadala-team-up-emerge-as-frontrunner-for-encube/128183510"
X Link 2026-02-11T02:38Z [---] followers, [--] engagements
"A high-stakes exchange at the ET RE-Pharma Summit [----] dives into: Beyond the Balance Sheet: Can Indian Pharma Break Free from Short-Term ROI Thinking Register now: #ETREPharma #REPharmaSummit #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-11T08:48Z [---] followers, [--] engagements
"Bhushan Akshikar Managing Director GlaxoSmithKline Pharmaceuticals Limited Praveen Rao Akkinepally Country President & Managing Director AstraZeneca India Dr. Mahesh Patel Chief Mentor Drug Discovery Wockhardt"
X Link 2026-02-11T08:48Z [---] followers, [---] engagements
"A sharp industry exchange at the ET RE-Pharma Summit [----] takes on: In-Licensing Incubators & Innovation: Can India Match Chinas Pharma Playbook Register now: #ETREPharma #REPharmaSummit #IndianPharma #PharmaInnovation https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-11T09:03Z [---] followers, [--] engagements
"Dr. Taslimarif Saiyed Director and CEO Centre for Cellular and Molecular Platforms (C-CAMP) Amit Mookim Chief Executive Officer Immuneel Therapeutics Pvt Ltd Bhargav Sri Prakash Research Scientist CEO FriendsLearn & Carnegie Mellon University Digital Vaccine Project"
X Link 2026-02-11T09:03Z [---] followers, [--] engagements
"Aurobindo expects [----] to be inflection year for biosimilar biz: CEO #Pharma I #Biosimilars I #Europe I #US I #sales I #growth I #oncology I #Q3Results I @AurobindoGlobal Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/aurobindo-expects-2029-to-be-inflection-year-for-biosimilar-biz-ceo/128209029 https://pharma.economictimes.indiatimes.com/news/pharma-industry/aurobindo-expects-2029-to-be-inflection-year-for-biosimilar-biz-ceo/128209029"
X Link 2026-02-11T13:20Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] Vyankatesh Patola Solution Consultant Hexagon highlights how bringing innovators technology leaders and pharma decision-makers together creates real industry leverage. Know more: #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T08:55Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] the industry presentation The Circle of Trust Authentic Redefined puts the spotlight on authenticity in an increasingly complex supply chain. Know more: #ETREPharma #REPharmaSummit #PharmaInnovation https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T11:00Z [---] followers, [--] engagements
"Delhi HC refuses to stay order allowing Dr Reddy's to export semaglutide #Semaglutide I #Drug I #weight_loss I #diabetes I #patent I #Injunction_plea I #DelhiHighCourt I @drreddys I @NovoNordiskIN Read more: https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/delhi-hc-refuses-to-stay-order-allowing-dr-reddys-to-export-semaglutide/125940142 https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/delhi-hc-refuses-to-stay-order-allowing-dr-reddys-to-export-semaglutide/125940142"
X Link 2025-12-13T05:05Z [---] followers, [--] engagements
"Dr Reddys expects to launch Semaglutide generic in Canada by May #GLP_1 I #Semaglutide I #generic I #Canada I #India I #launches I #approval I #Pill_application I @drreddys I #Q3_earnings Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/dr-reddys-expects-to-launch-semaglutide-generic-in-canada-by-may/127139141 https://pharma.economictimes.indiatimes.com/news/pharma-industry/dr-reddys-expects-to-launch-semaglutide-generic-in-canada-by-may/127139141"
X Link 2026-01-22T11:47Z [---] followers, [--] engagements
"Aurobindo Pharma formulations facility gets [--] observations from FDA #Pharma I #manufacturing I @FDA I #inspection I #observations I #AUROBINDOPHARMA Read more: https://pharma.economictimes.indiatimes.com/news/regulatory-update/aurobindo-pharma-formulations-facility-gets-11-observations-from-fda/128060176 https://pharma.economictimes.indiatimes.com/news/regulatory-update/aurobindo-pharma-formulations-facility-gets-11-observations-from-fda/128060176"
X Link 2026-02-09T07:03Z [---] followers, [--] engagements
"US FDA says Novo's obesity pill TV Ad is false or misleading #Obesity I #weightloss I #pill I #advertisements I #TV I @FDA I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/regulatory-update/us-fda-says-novos-obesity-pill-tv-ad-is-false-or-misleading/128135306 https://pharma.economictimes.indiatimes.com/news/regulatory-update/us-fda-says-novos-obesity-pill-tv-ad-is-false-or-misleading/128135306"
X Link 2026-02-10T02:21Z [---] followers, [--] engagements
"Ganpat Anchaliya Head of Corporate Center India at Novartis will share insights at the ET RE-Pharma Summit [----] on how global capability centres are evolving to support R&D. Register now: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-10T06:31Z [---] followers, [--] engagements
"We are pleased to welcome bioMrieux as the Supporting Partner for the ET RE-Pharma Summit [----]. As a global leader in in vitro diagnostics bioMrieux plays a critical role in strengthening quality safety and innovation. Register now: #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-12T17:46Z [---] followers, [--] engagements
"Dr. Annam Visala Joint Drugs Controller (India) CDSCO delivers the Keynote Address at the ET RE-Pharma Summit [----] spotlighting the evolving regulatory landscape shaping Indias pharma growth story. Know more: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T04:58Z [---] followers, [--] engagements
"The stage heats up at the ET RE-Pharma Summit [----] with a powerful exchange on Breaking the Mould: Indian Pharmas Reckoning with Innovation Fatigue. Know more: #ETREPharma #REPharmaSummit #IndianPharma #PharmaInnovation https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T05:49Z [---] followers, [--] engagements
"The conversation brings together: Dr. Annam Visala Joint Drugs Controller (India) CDSCO Achin Gupta MD & Global CEO Designate Cipla Ltd Meenakshi Nevatia Country President & Managing Director Pfizer India Sanjiv Navangul MD & CEO Bharat Serums and Vaccines"
X Link 2026-02-13T05:53Z [---] followers, [--] engagements
"Is Indian pharma innovating enough or just innovating safely The stage heats up at the ET RE-Pharma Summit [----] with a powerful exchange on Breaking the Mould: Indian Pharmas Reckoning with Innovation Fatigue. Know more: #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T05:54Z [---] followers, [--] engagements
"Dr. Annam Visala Joint Drugs Controller (India) CDSCO Achin Gupta MD & Global CEO Designate Cipla Ltd Meenakshi Nevatia Country President & Managing Director @pfizer India Sanjiv Navangul MD & CEO Bharat Serums and Vaccines Nandini Piramal Chairperson @PiramalPharma"
X Link 2026-02-13T05:57Z [---] followers, [--] engagements
"The Chief Guest Address by Manoj Joshi IAS Secretary Department of Pharmaceuticals Government of India at the 6th Edition ET RE-Pharma Summit [----]. Know more: #ETREPharma #REPharmaSummit #IndianPharma #PharmaPolicy https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T06:41Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] the industry presentation of Jenil Dedhia Business Head Leucine. on Leucine AI for Pharma: From Compliance to Competitive Advantage. Know more: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T07:43Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] a thought-provoking exchange takes on the question: Beyond the Balance Sheet: Can Indian Pharma Break Free from Short-Term ROI Thinking Know more: #ETREPharma #REPharmaSummit #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T08:09Z [---] followers, [---] engagements
"Bringing diverse and powerful perspectives to the stage: * Bhushan Akshikar Managing Director GSK Ltd * Praveen Rao Akkinepally Country President & Managing Director AstraZeneca India * Dr. Mahesh Patel Chief Mentor Drug Discovery Wockhardt"
X Link 2026-02-13T08:11Z [---] followers, [--] engagements
"Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant #Pharma I #CEO I #Ouster I #Plummenting_sales I #earnings I #pipeline_pressure I @sanofi Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/sanofi-ousts-ceo-hudson-after-stalled-turnaround-at-vaccine-giant/128252779 https://pharma.economictimes.indiatimes.com/news/pharma-industry/sanofi-ousts-ceo-hudson-after-stalled-turnaround-at-vaccine-giant/128252779"
X Link 2026-02-13T10:01Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] the Big Picture Address titled Women in Pharma From Presence to Power brings a powerful leadership narrative to the stage. Know more: #ETREPharma #REPharmaSummit #WomenInPharma #PharmaLeadership https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T10:26Z [---] followers, [--] engagements
"Excellence in Pharma Medical Devices: Cytosorb by Converge Biotech Excellence in Research & Development: Orchid Pharma India Limited Excellence in Rural Health Initiative: Vistara (Rural Div.) Dr. Reddy's Ltd. Excellence in Supply Chain Logistics & Distribution: CIPLA LIMITED"
X Link 2026-02-13T14:38Z [---] followers, [--] engagements
"Excellence takes centre stage at the 6th Edition of the #ETRePharmaAwards [----]. We honour the pioneers whose work is redefining standards across innovation quality and leadership in the pharmaceutical industry. Know more: #REPharmaAwards #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T14:56Z [---] followers, [--] engagements
"The Valedictory Address at the 6th edition of the ET RE-Pharma Summit [----] is delivered by Dr. Habil F. Khorakiwala Founder Chairman Wockhardt a pioneer whose career mirrors the evolution of Indian pharma itself. Know more: #ETREPharma #REPharmaSummit https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T12:32Z [---] followers, [---] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] P.V. Raghavendra Rao Group CFO Extrovis AG highlights a clear priority for pharma impactful patient-centric innovation. Know more: #ETREPharma #REPharmaSummit #PharmaInnovation #PatientCentricity https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T13:23Z [---] followers, [--] engagements
"At the 6th edition of the ET RE-Pharma Summit [----] Mukesh Kumar Chief Scientific Officer Clinexel reflects on the tangible progress made over the past year. Know more: #ETREPharma #REPharmaSummit #ClinicalResearch #PharmaInnovation #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T13:26Z [---] followers, [--] engagements
"Excellence in Formulations Akums Drugs and Pharmaceuticals Pharma Innovation of the Year CIPLA XTERNA Excellence in Valuable Collaboration VeGen Labs LLP Excellence in Valuable Collaboration Clearsynth Labs Limited"
X Link 2026-02-13T14:47Z [---] followers, [--] engagements
"Recognising this years distinguished winners: Pharma Company of the Year AstraZeneca Pharma India Limited Emerging Woman Icon of the Year Vaibhavi Shah Pharma Leader of the Year Dr. Shrinivas Purandare Pharma Leader of the Year Muralidhar Reddy N"
X Link 2026-02-13T14:56Z [---] followers, [--] engagements
"Veterinary Pharma Company of the Year SUSHIMA LABORATORIES MSME Pharma Company of the Year Eskay Speciality Chemicals MSME Pharma Company of the Year Invengene Private Limited"
X Link 2026-02-13T14:56Z [---] followers, [--] engagements
"We proudly honour the outstanding organisations and leaders who have set new benchmarks across innovation research manufacturing digital transformation and leadership in Indian pharma. Know more: #ETREPharmaAwards #REPharmaAwards #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T15:00Z [---] followers, [--] engagements
"Biopharma SHAKTI to Anchor Industrys Innovation Drive; Support for Late-Stage Trials Under Review: Pharma Secy #Biopharma I #Biopharma_SHAKTI I #Budget2026 I #biologics I #biosimilars I #development I #support I #manufacturing I @DoPTGoI Read more: https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/biopharma-shakti-to-anchor-industrys-innovation-drive-support-for-late-stage-trials-under-review-pharma-secy/128330763utm_source=top_story&utm_medium=homepage"
X Link 2026-02-14T03:11Z [---] followers, [--] engagements
"The spotlight shines on those who dare to innovate at the #ETRePharmaAwards [----]. From scientific breakthroughs to strategic excellence we celebrate the leaders and organisations redefining healthcare outcomes. Know more: #REPharmaAwards #IndianPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-13T14:43Z [---] followers, [--] engagements
"Honouring this years distinguished winners: Excellence in Training and Development: Royed Training Services Excellence in Use of Technology Zydus Lifesciences Limited Excellence in Digital Transformation CIPLA LIMITED"
X Link 2026-02-13T14:47Z [---] followers, [--] engagements
"AbbVie Deal Crowns [--] Years of Determination; Commercial Leap Is the Next Task Says Glenn Saldanha #Pharma I #Innovation I #research I #reward I #commitment I @glenmarkpharma I #IGI I #ISB_2001 Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/abbvie-deal-crowns-25-years-of-determination-commercial-leap-is-the-next-task-says-glenn-saldanha/128313414 https://pharma.economictimes.indiatimes.com/news/pharma-industry/abbvie-deal-crowns-25-years-of-determination-commercial-leap-is-the-next-task-says-glenn-saldanha/128313414"
X Link 2026-02-13T16:39Z [---] followers, [--] engagements
"Focus on Building an Innovative Pipeline with Differentiated Assets: Dilip Shanghvi #Pipeline I #new_assets I #Differentiated_profile I #NewMarkets I #growth I #Longterm_value I #Dilip_Shanghvi I @SunPharma_Live Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/focus-on-building-an-innovative-pipeline-with-differentiated-assets-dilip-shanghvi/128316677utm_source=top_story&utm_medium=homepage"
X Link 2026-02-13T17:31Z [---] followers, [--] engagements
"US could take action including fines against Hims after brief Wegovy copy launch #Wegovy I #weightloss_drug I #Pill I #copy I #US I #sales I #action I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/us-could-take-action-including-fines-against-hims-after-brief-wegovy-copy-launch/128330747 https://pharma.economictimes.indiatimes.com/news/pharma-industry/us-could-take-action-including-fines-against-hims-after-brief-wegovy-copy-launch/128330747"
X Link 2026-02-15T17:17Z [---] followers, [--] engagements
"US FDA approves Journey Medical's drug for long-term skin condition #long_term_skin_condition #FDA #approval #pharmaceutical Read more: https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/us-fda-approves-journey-medicals-drug-for-long-term-skin-condition/114967443 https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/us-fda-approves-journey-medicals-drug-for-long-term-skin-condition/114967443"
X Link 2024-11-05T10:30Z [---] followers, [--] engagements
"Sanofi begins Phase [--] trial of pneumococcal vaccine with SK bioscience #PCV I #Phase3 I #US I #Europe I #SouthKorea I #Phase2 I #global_vaccinecommercialization I @sanofi Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/sanofi-begins-phase-3-trial-of-pneumococcal-vaccine-with-sk-bioscience/116677739 https://pharma.economictimes.indiatimes.com/news/research-and-development/sanofi-begins-phase-3-trial-of-pneumococcal-vaccine-with-sk-bioscience/116677739"
X Link 2024-12-26T11:11Z [---] followers, [--] engagements
"Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments #Obesity I #Weight_loss I #partnership I #GPCRtargets I #drug I #Development I @Septerna_Inc I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-strikes-2-2-billion-deal-with-septerna-to-develop-new-obesity-treatments/121164760 https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-strikes-2-2-billion-deal-with-septerna-to-develop-new-obesity-treatments/121164760"
X Link 2025-05-15T02:36Z [---] followers, [--] engagements
"Torrent Pharmaceuticals plans Semaglutide rollout post patent expiry #Semaglutide I #Weight_Loss I #drug I #Type_2diabetes I #Ozempic I #Wegovy I #patent I #Generic_launch I @TorrentPharmaIn Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/torrent-pharmaceuticals-gears-up-for-semaglutide-launch-post-patent-expiry/122963757 https://pharma.economictimes.indiatimes.com/news/pharma-industry/torrent-pharmaceuticals-gears-up-for-semaglutide-launch-post-patent-expiry/122963757"
X Link 2025-07-29T05:44Z [---] followers, [--] engagements
"Innovent's weight-loss drug highlights China challenge for Novo Lilly #China I #Weight_loss I #drug I #Challenger I #Zepbound I #Wegovy I #Innovent_Biologics I @novonordisk I @EliLillyandCo Read more: http://pharma.economictimes.indiatimes.com/news/pharma-industry/innovents-weight-loss-drug-poses-tough-competition-for-novo-nordisk-and-eli-lilly-in-china/124059014 http://pharma.economictimes.indiatimes.com/news/pharma-industry/innovents-weight-loss-drug-poses-tough-competition-for-novo-nordisk-and-eli-lilly-in-china/124059014"
X Link 2025-09-23T05:47Z [---] followers, [---] engagements
"At the ETPharma Future Ready Supply Chain Summit experts discuss From Factory to Pharmacy: Localisation & Anti-Counterfeit Strategies for Patient-Centric Safety. Know More: #ETPharma #ETFutureReadySC #FutureReadySupplyChain #PharmaLogistics https://shorturl.at/GiFkI https://shorturl.at/GiFkI"
X Link 2025-09-24T09:17Z [---] followers, [--] engagements
"Novartis to acquire Avidity Biosciences for about $12 billion #Pharma I #acquisition I #12bn_buyout I #Cardiac_therapy I #Spinco I @Novartis I @aviditybio Read more: https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/novartis-to-acquire-avidity-biosciences-for-about-12-billion/124837673 https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/novartis-to-acquire-avidity-biosciences-for-about-12-billion/124837673"
X Link 2025-10-27T06:23Z [---] followers, [--] engagements
"HC lets Dr Reddy's export Semaglutide blocks India sales till March '26 #Semaglutide I #patent I #dispute I #Exports I #Production I @novonordisk I @drreddys Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/hc-lets-dr-reddys-export-semaglutide-blocks-india-sales-till-march-26/125731326 https://pharma.economictimes.indiatimes.com/news/pharma-industry/hc-lets-dr-reddys-export-semaglutide-blocks-india-sales-till-march-26/125731326"
X Link 2025-12-03T05:46Z [---] followers, [--] engagements
"Featuring: Prasun Guha Vice President and Head Biologics Dr. Reddys Laboratories Dr. Sandeep Athalye Chief Executive Officer Kashiv Biosciences Dr. Shubhadeep D Sinha Senior Vice President and Medical Director Hetero Drugs"
X Link 2025-12-09T10:31Z [---] followers, [--] engagements
"Dr. Reddys launches Hepatitis E vaccine in India #Hepatitis_E I #Vaccine I #India I #launch I #recombinant_tech I @drreddys Read more: https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/dr-reddys-launches-hepatitis-e-vaccine-in-india/126384931 https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/dr-reddys-launches-hepatitis-e-vaccine-in-india/126384931"
X Link 2026-01-07T10:17Z [---] followers, [--] engagements
"AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty #Pharma I #cancer_drugmaker I #PD_1_asset I #deal I #dispute I #US I @AnaptysBio I @GSK Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/anaptysbio-seeks-partial-dismissal-in-gsk-oncology-unit-dispute-over-drug-royalty/126446315 https://pharma.economictimes.indiatimes.com/news/pharma-industry/anaptysbio-seeks-partial-dismissal-in-gsk-oncology-unit-dispute-over-drug-royalty/126446315"
X Link 2026-01-10T12:39Z [---] followers, [--] engagements
"Novo Nordisk expands diabetes cell therapy partnership with Aspect Biosystems #cell_therapy I #diabetes I #Insulin I #pact I #AspectBiosystems I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-expands-diabetes-cell-therapy-partnership-with-aspect-biosystems/126909930 https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-expands-diabetes-cell-therapy-partnership-with-aspect-biosystems/126909930"
X Link 2026-01-21T08:57Z [---] followers, [--] engagements
"Novo Nordisk sued for allegedly monopolizing diabetes drug Victoza #Liraglutide I #GLP_1 I #Victoza I #diabetes I #Market_monopoly I #US I #Lawsuit I #TevaPharma I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-sued-for-allegedly-monopolizing-diabetes-drug-victoza/127467437 https://pharma.economictimes.indiatimes.com/news/pharma-industry/novo-nordisk-sued-for-allegedly-monopolizing-diabetes-drug-victoza/127467437"
X Link 2026-01-25T10:22Z [---] followers, [--] engagements
"Join Amit Pradhan VP - IT & CIO Dixon Technologies at India Inc on the Move: Smart and Sustainable Manufacturing presented by @EconomicTimes and powered by @ROKAutomation on February [--] [----] Fairmont Mumbai. #IIOTM2026 #IndiaIncOnTheMove https://iiotm2026.com/site/iiotm/2346 https://iiotm2026.com/site/iiotm/2346"
X Link 2026-01-27T13:46Z [---] followers, [--] engagements
"Roche' obesity shot shows 22.5% weight loss #Obesity I #weight_loss I #drug I #GLP_1 I #phase_2 I @Roche I @EliLillyandCo I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/roche-obesity-drug-shows-22-5-weight-loss-as-it-seeks-to-catch-up-with-lilly-novo/127680020 https://pharma.economictimes.indiatimes.com/news/research-and-development/roche-obesity-drug-shows-22-5-weight-loss-as-it-seeks-to-catch-up-with-lilly-novo/127680020"
X Link 2026-01-28T08:57Z [---] followers, [--] engagements
"Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly data shows #Wegovy I #Ozempic I #marketing I #drugs I #spent I #US I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/novos-wegovy-and-ozempic-us-advertising-spend-doubles-rival-eli-lilly-data-shows/127748737 https://pharma.economictimes.indiatimes.com/news/pharma-industry/novos-wegovy-and-ozempic-us-advertising-spend-doubles-rival-eli-lilly-data-shows/127748737"
X Link 2026-01-30T02:27Z [---] followers, [--] engagements
"Novo's Wegovy pill surpasses [-----] prescriptions in second full week #Wegovy I #weight_loss I #pill I #sales I #US I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/novos-wegovy-pill-surpasses-26000-prescriptions-in-second-full-week/127812768 https://pharma.economictimes.indiatimes.com/news/pharma-industry/novos-wegovy-pill-surpasses-26000-prescriptions-in-second-full-week/127812768"
X Link 2026-01-31T08:56Z [---] followers, [--] engagements
"Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push #Weight_loss I #Injectable I #manufacturing I #Pennsylvania I #US I @EliLillyandCo Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/eli-lilly-to-build-3-5-billion-pennsylvania-plant-in-us-manufacturing-push/127812765 https://pharma.economictimes.indiatimes.com/news/pharma-industry/eli-lilly-to-build-3-5-billion-pennsylvania-plant-in-us-manufacturing-push/127812765"
X Link 2026-01-31T09:00Z [---] followers, [--] engagements
"Union Budget 2026: Healthcare Biopharma Emerge as Growth Engines with [-----] Cr Bio SHAKTI Push #BioSHAKTI I #Biopharma I #Biotech I #India I #Budget2026_27 I @FinMinIndia I @DBTIndia I @DoPTGoI Read more: https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/union-budget-2026-10000-cr-investment-to-transform-india-into-global-biopharma-hub/127835773 https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/union-budget-2026-10000-cr-investment-to-transform-india-into-global-biopharma-hub/127835773"
X Link 2026-02-01T13:32Z [---] followers, [--] engagements
"Dr. Ganesh Sangle brings hands-on expertise in translating innovation into pharma pipelines. At the ET RE-Pharma Summit [----] the Vice President and Program Director Innovation Projects at Alixer Nexgen Therapeutics. #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-02T09:49Z [---] followers, [--] engagements
"Manish Arora AVP & GM Eli Lilly Services India joins the ET RE-Pharma Summit [----] to discuss pharma GCCs R&D enablement and digital operations. [--] Feb [----] Sofitel BKC Mumbai Register: #ETREPharma https://pharma.economictimes.indiatimes.com/re-pharma-summit https://pharma.economictimes.indiatimes.com/re-pharma-summit"
X Link 2026-02-03T04:30Z [---] followers, [--] engagements
"US FDA rejects AstraZeneca's easier-to-use version of lupus therapy #Lupus_therapy I #application I #US I #rejection I @US_FDA I @AstraZeneca Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/us-fda-rejects-astrazenecas-easier-to-use-version-of-lupus-therapy/127881242 https://pharma.economictimes.indiatimes.com/news/pharma-industry/us-fda-rejects-astrazenecas-easier-to-use-version-of-lupus-therapy/127881242"
X Link 2026-02-04T04:54Z [---] followers, [--] engagements
"How a Swiss drugmaker built its largest GCC in Hyderabad #GCC I #India I #Hyderabad I #25yrs I #research I #talent I @Novartis Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/how-a-swiss-drugmaker-built-its-largest-gcc-in-hyderabad/127912209 https://pharma.economictimes.indiatimes.com/news/pharma-industry/how-a-swiss-drugmaker-built-its-largest-gcc-in-hyderabad/127912209"
X Link 2026-02-05T06:09Z [---] followers, [--] engagements
"Novo Nordisk warns 'unprecedented' price pressure to hit sales #Pharma I #earnings I #Ozempic I #Wegovy I #Sales I #2026_Outlook I #Price_pressure I #generics I @novonordisk Read more: https://pharma.economictimes.indiatimes.com/news/financial-performance/wegovy-maker-novo-nordisk-warns-unprecedented-price-pressure-to-hit-sales/127912126 https://pharma.economictimes.indiatimes.com/news/financial-performance/wegovy-maker-novo-nordisk-warns-unprecedented-price-pressure-to-hit-sales/127912126"
X Link 2026-02-05T06:15Z [---] followers, [--] engagements
"Inhibikase Therapeutics stops Parkinson's drug development as it fails to show benefits in study #ParkinsonsDisease #Neurology #MedicalResearch #DrugDevelopment #Healthcare #ClinicalTrials #Neuroscience Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/inhibikase-therapeutics-stops-parkinsons-drug-development-as-it-fails-to-show-benefits-in-study/117713877 https://pharma.economictimes.indiatimes.com/news/research-and-development/inhibikase-therapeutics-stops-parkinsons-drug-development-as-it-fails-to-show-benefits-in-study/117713877"
X Link 2025-01-30T07:31Z [---] followers, [--] engagements
"Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline #Acquisition I #deal I #Pharma I #Neuro_drug I #CNS I #French_drugmaker I #VigilNeuroscience I @sanofi Read more: https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/sanofi-to-acquire-vigil-neuroscience-in-470-million-deal-to-boost-neurological-pipeline/121327417 https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/sanofi-to-acquire-vigil-neuroscience-in-470-million-deal-to-boost-neurological-pipeline/121327417"
X Link 2025-05-22T03:22Z [---] followers, [--] engagements
"Zealand Pharma pauses development of early-stage obesity drug candidate #Obesity I #Weight_loss I #GLP_1 I #trial I #development I #Zeland_Pharma Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/zealand-pharma-pauses-development-of-early-stage-obesity-drug-candidate/125333271 https://pharma.economictimes.indiatimes.com/news/research-and-development/zealand-pharma-pauses-development-of-early-stage-obesity-drug-candidate/125333271"
X Link 2025-11-15T13:16Z [---] followers, [--] engagements
"Were thrilled to welcome Dr. Ganesh Sangle Vice President Innovation Projects Alixer Nexgen Therapeutics (subsidiary of Alkem Laboratories) as a distinguished speaker at The Economic Times Biotech Leadership Symposium [----]. Register Now: #ETBioTech https://pharma.economictimes.indiatimes.com/biotech-leadership-symposium https://pharma.economictimes.indiatimes.com/biotech-leadership-symposium"
X Link 2025-11-28T09:31Z [---] followers, [--] engagements
"Dr Reddys inks $370 million deal for cancer candidate Eftilagimod Alfa select market rights #Cancer I #Drug I #immunotherapy I #commercial_rights I @drreddys I @Immutep Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/dr-reddys-inks-370-million-deal-for-cancer-candidate-eftilagimod-alfa-select-market-rights/125832771 https://pharma.economictimes.indiatimes.com/news/pharma-industry/dr-reddys-inks-370-million-deal-for-cancer-candidate-eftilagimod-alfa-select-market-rights/125832771"
X Link 2025-12-10T03:27Z [---] followers, [--] engagements
"Biotech Boom: Is Indias Pharma Blueprint Ready to Ride the Next Big Rush #Biotech I #Biosimilars #India I #Investment I #Regulations I @IndiaHaier I @thermofisher I @Bioconlimited I @BIRAC_2012 I @ccmb_csir I @ActImmuno Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/biotech-boom-is-indias-pharma-blueprint-ready-to-ride-the-next-big-rush/125917359utm_source=top_story&utm_medium=homepage"
X Link 2025-12-12T02:28Z [---] followers, [--] engagements
"Terns Pharmaceuticals oral obesity drug shows promise in early study shares jump #Obesitydrug I #USdrugmarket I #weightlosspills I #experimentaldrug I #earlystagestudy I #dailyversion I #Sharepricerise I @novonordisk I @EliLillyandCo Read more: https://pharma.economictimes.indiatimes.com/news/financial-performance/terns-pharmaceuticals-oral-obesity-drug-shows-promise-in-early-study-shares-jump/113199755 https://pharma.economictimes.indiatimes.com/news/financial-performance/terns-pharmaceuticals-oral-obesity-drug-shows-promise-in-early-study-shares-jump/113199755"
X Link 2024-09-10T06:06Z [---] followers, [--] engagements
"Takeda-backed Ascentage Pharma targets $1.8 bln valuation in US IPO #AscentagePharma #IPO #NasdaqListing #PharmaceuticalIndustry #USChinaRelations #CancerTherapies #Olverembatinib #HongKongStockExchange #TradeTensions Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/takeda-backed-ascentage-pharma-targets-1-8-bln-valuation-in-us-ipo/117445783 https://pharma.economictimes.indiatimes.com/news/pharma-industry/takeda-backed-ascentage-pharma-targets-1-8-bln-valuation-in-us-ipo/117445783"
X Link 2025-01-22T09:16Z [---] followers, [--] engagements
"AstraZeneca signs $5 billion research deal with China's CSPC #deal I #research_partnership I #drugs I #AI I #Innovation I @AstraZeneca I #CSPC Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/astrazeneca-and-cspc-pharmaceutical-group-sign-5-billion-research-partnership/121826527 https://pharma.economictimes.indiatimes.com/news/pharma-industry/astrazeneca-and-cspc-pharmaceutical-group-sign-5-billion-research-partnership/121826527"
X Link 2025-06-14T02:38Z [---] followers, [--] engagements
"Agilent Technologies launches Biopharma Experience Centre in Hyderabad #Biopharma_centre I #Tech_service I #US I #India_expansion I #drug_development I @Agilent Read more: https://pharma.economictimes.indiatimes.com/news/pharmatech/agilent-technologies-launches-biopharma-experience-centre-in-hyderabad/122977394 https://pharma.economictimes.indiatimes.com/news/pharmatech/agilent-technologies-launches-biopharma-experience-centre-in-hyderabad/122977394"
X Link 2025-07-30T02:29Z [---] followers, [--] engagements
"Amylyx to stop development of rare brain disorder drug after trial failure #Drug I #rare_disorder I #Brain I #Trials I #AmylyxPharmaceuticals Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/amylyx-pharmaceuticals-halts-development-of-experimental-drug-for-rare-brain-disorder-after-failed-trial/123546107 https://pharma.economictimes.indiatimes.com/news/pharma-industry/amylyx-pharmaceuticals-halts-development-of-experimental-drug-for-rare-brain-disorder-after-failed-trial/123546107"
X Link 2025-08-28T05:41Z [---] followers, [--] engagements
"Speakers: Barak Shaik Tulla Sr VP Sun Pharma Uday Sharan Director of Supply Chain Edwards Lifesciences Abhinav Srivastava Partner Vector Consulting Group Moderator: Ryan Veigas Consultant"
X Link 2025-09-24T09:46Z [---] followers, [--] engagements
"At the ET Biotech Leadership Symposium [----] this session brings together leaders shaping the future of biologics to examine whether India can recreate its global generics triumph in the biosimilars arena. Register Now: #ETBioTech #BiotechLeadership https://pharma.economictimes.indiatimes.com/biotech-leadership-symposium https://pharma.economictimes.indiatimes.com/biotech-leadership-symposium"
X Link 2025-12-09T10:30Z [---] followers, [--] engagements
"Join Venkatnarayan V VP & Digital Transformation Leader GMO Dr. Reddys Laboratories at India Inc on the Move: Smart and Sustainable Manufacturing presented by @EconomicTimes and powered by @ROKAutomation on Feb [--] [----] Fairmont Mumbai. #IIOTM2026 https://iiotm2026.com/site/iiotm/2346 https://iiotm2026.com/site/iiotm/2346"
X Link 2026-01-22T12:20Z [---] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing